Cap cost sharing for prescription insulin drugs

SB 227 would limit how much patients pay out-of-pocket for prescription insulin each month. It caps cost sharing at $35 per month for all insulin drugs covered under the bill. This directly affects people with diabetes who rely on insulin prescriptions. The law would require health plans and insurers to cover insulin costs above $35 at no additional charge to the patient.